Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 7:45 pm Sale | 13G | TG THERAPEUTICS INC. TGTX | Darwin Global Management Ltd. | 0 0.000% | -4,046,598 (Position Closed) | View |
| 2024-09-03 5:22 pm Purchase | 13G | INSMED INC- INSM | Darwin Global Management Ltd. | 9,717,822 5.700% | 9,717,822 (New Position) | View |
| 2024-02-14 3:30 pm Sale | 13G | TG THERAPEUTICS INC. TGTX | Darwin Global Management Ltd. | 4,046,598 2.700% | -6,404,643 (-61.28%) | View |
| 2023-06-28 4:45 pm Purchase | 13D | AMBRX BIOPHARMA INC AMAM | Darwin Global Management Ltd. | 116,820,452 27.500% | 37,688,441 (+47.63%) | View |
| 2023-05-25 4:39 pm Unchanged | 13D | AMBRX BIOPHARMA INC AMAM | Darwin Global Management Ltd. | 79,132,011 20.500% | 0 (Unchanged) | View |
| 2023-04-03 08:00 am Purchase | 13G | TG THERAPEUTICS INC. TGTX | Darwin Global Management Ltd. | 10,451,241 7.100% | 10,451,241 (New Position) | View |
| 2023-03-08 10:49 am Purchase | 13D | AMBRX BIOPHARMA INC AMAM | Darwin Global Management Ltd. | 79,132,011 26.400% | 26,040,588 (+49.05%) | View |
| 2023-02-14 09:30 am Purchase | 13G | AMBRX BIOPHARMA INC AMAM | Darwin Global Management Ltd. | 53,091,423 19.600% | 2,450,000 (+4.84%) | View |
| 2022-12-19 08:30 am Purchase | 13G | AMBRX BIOPHARMA INC AMAM | Darwin Global Management Ltd. | 50,641,423 18.700% | 50,641,423 (New Position) | View |